Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
48 Cards in this Set
- Front
- Back
Factors that influence drug concentration |
1. Absorption 2. Distribution 3. Biotransformation 4. Elimination |
|
Transport physiology |
Transport categories are based on whether energy is required to move a substance across the body's compartments: 1. Active transport 2. Passive transport |
|
Active transport |
Requires energy to move a substance from an area of low concentration go an area of high concentration |
|
Mitochondria produce |
ATP |
|
ATP breaks down to |
ADP producing biochemical energy
This energy is used to facilitate the movement of ions "up" the concentration gradient |
|
Passive transport |
Movement of a substance without the use of energy from an area of high concentration to an area of low concentration |
|
Three processes of passive transport |
1. Diffusion 2. Osmosis 3. Filtration |
|
Drug absorption |
The process of movement of a drug from the site of application into the specific target |
|
Factors that affect the rate of drug absorption |
1. Drug solubility 2. Drug concentration 3. Drug pH 4. Site of absorption 5. Absorbing surface area 6. Circulatory status 7. Bioavailability (the amount of medication in systemic circulation) |
|
Drug solubility |
The tendency of a drug to dissolve |
|
Drug concentration |
•Drugs given in high concentration are more quickly absorbed than those in low concentration •Drugs administered by more than one rout may have various concentrations |
|
Drug pH |
•Acid vs basic (alkaline) •Acidic drugs are more rapidly absorbed in acidic environments (stomach) •Basic drugs are more rapidly absorbed in alkaline environments (kidneys) |
|
Site of absorption |
Site of absorption affects the rate of absorption |
|
Absorbing surface area |
Drugs are absorbed more quickly from large surface areas |
|
Blood supply to the site of absorption |
Different body tissues and organs have varied degrees of blood supply |
|
Bioavailability |
The amount of drug that is still active after it reaches its target tissue |
|
Distribution |
The process whereby a drug is transported from the site of absorption to the site of action |
|
Factors that affect distribution |
1. Cardiovascular function 2. Regional blood flow 3. Drug storage reservoirs 4. Physiological barriers |
|
Distribution - Cardiovascular function |
Impared cardiovascular function results in slower and unpredictable drug distribution with decreased perfusion and drug delivery |
|
Distribution - regional blood flow |
Regional as well as systemic blood flow can impact drug distribution by causing the drug to not reach all parts of the intended target |
|
Distribution - physiological barriers |
Two main barriers: blood-brain barrier/blood-cerebrospinal barriers are tightly packed cell membranes that restrict damaging drugs and toxins. Only non protein bound, highly lipid soluble drugs can cross the barriers of the CNS |
|
Biotransformation |
Once in the body, a drug is metabolized or broken down into different chemicals (metabolites) 1. Makes it into a more or less active metabolite 2. Makes it more water soluble (to facilitate eliminafion) Biotransformation usually occurs in the liver but can also occur in the kidneys, lungs, GI tract |
|
Biotransformation: Hepatic "first-pass" metabolism |
The first-pass metabolism or presystemic metabolism is the phenomenon which occurs whenever the drug administered orally, enters the liver and suffers extensive biotransformation to such an extent that bioavailability is drastically reduced, thus showing subtherapeutic action The first-pass metabolism or presystemic metabolism is the phenomenon which occurs whenever the drug administered orally, enters the liver and suffers extensive biotransformation to such an extent that bioavailability is drastically reduced, thus showing subtherapeutic action |
|
Elimination |
Movement of a drug, or its metabolites from tissues back into circulation and circulation to the organs of excretion |
|
Drug half-life |
The time required for the total amount of a drug in the body to diminish by half |
|
Predictable responses |
Anticipate responses beyond the desired effect |
|
Iatrogenic responses |
An adverse condition inadvertently induced in a patient by the treatment given |
|
Therapeutic threshold |
Is the minimum concentration necessary for a drug to produce it's desired effect |
|
Autonomic nervous system |
Part of the PNS which controls the body's autamatic or involuntary functions such as: •BP •Cardiac function •Bladder •Temperature |
|
Neurochemical transmission |
•Process of chemical signaling between cells •Synthesis of chemical signals •Signals are stored in nerve terminal •Signals released from the nerve ending •Signal is bound to a receptor |
|
The vagus nerve is the what cranial nerve? |
10th (Cranial nerve X) |
|
Acetylcholine |
Is the neurotransmitter that initiates PNS responses (enables vagal nerve stimulation) |
|
Parasympathetic Nervous system |
•Decreases HR (normal HR) •Bronchoconstriction •Increased GI smooth muscle activity •Digestive enzymes •Pupillary constriction (normal pupils) •Salvation •Hypotension (normal bp) •Urine production |
|
Sympathetic nervous system |
•Dry mouth •Tachycardia •Increased myocardial contractility •Hypertension •Dialated pupils •Shunting of blood to vital organs/muscles •Bronchodilation •Increased sweat glands secretion •Converts glycogen to glucose |
|
Anticholinergic drugs block what? |
PNS influence |
|
Cholinergic drugs mimic what? |
PNS influence |
|
Cholinergic (PNS) |
Neurons and effector organs activated by acetylcholine are called cholinergic |
|
Adrenergic (SNS) |
Neuronal and effector organs are activated by norepinephrine/epinephrine are called adrenergic |
|
Adrenergic drugs cause .. |
Adrenaline effects in the body |
|
Antiadreneric drugs... |
Block the effects of adrenaline like drugs |
|
Epinephrine is a what agonist? |
Alpha and beta |
|
Alpha 1 |
Receptor stimulation causes artery and venous constriction |
|
Alpha 2 |
Receptor stimulation blocks norepinephrine release |
|
Beta 1 |
Receptor stimulation causes increased force and contractility of the heart |
|
Beta 2 |
Receptor stimulation causes bronchodilation in the lungs |
|
Sympathomimetics |
Mimic sympathetic stimulation |
|
Agonist |
Drug that bunds to a receptor and causes it to initiate the expected response |
|
Antagonist |
Drug binds to a site but do not cause the expected response |